174 related articles for article (PubMed ID: 26404136)
1. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles.
Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C
Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136
[TBL] [Abstract][Full Text] [Related]
2. Transferrin-modified Doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats.
Liu G; Mao J; Jiang Z; Sun T; Hu Y; Jiang Z; Zhang C; Dong J; Huang Q; Lan Q
Cancer Biother Radiopharm; 2013 Nov; 28(9):691-6. PubMed ID: 23786401
[TBL] [Abstract][Full Text] [Related]
3. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
[TBL] [Abstract][Full Text] [Related]
4. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model.
Wang CX; Huang LS; Hou LB; Jiang L; Yan ZT; Wang YL; Chen ZL
Brain Res; 2009 Mar; 1261():91-9. PubMed ID: 19401168
[TBL] [Abstract][Full Text] [Related]
6. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
[TBL] [Abstract][Full Text] [Related]
9. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.
Cabeza L; Ortiz R; Arias JL; Prados J; Ruiz Martínez MA; Entrena JM; Luque R; Melguizo C
Int J Nanomedicine; 2015; 10():1291-306. PubMed ID: 25709449
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.
De Juan BS; Von Briesen H; Gelperina SE; Kreuter J
J Drug Target; 2006 Nov; 14(9):614-22. PubMed ID: 17090397
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo.
Zhang L; Hou Y; Li C; Liu H; Wang Y
Arab J Gastroenterol; 2022 Nov; 23(4):263-269. PubMed ID: 35922259
[TBL] [Abstract][Full Text] [Related]
13. [Study of biocompatibility of polybutylcyanoacrylate nanoparticles].
Yang XX; Chen JH; Guo D
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1261-3. PubMed ID: 16234103
[TBL] [Abstract][Full Text] [Related]
14. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
[TBL] [Abstract][Full Text] [Related]
16. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
[TBL] [Abstract][Full Text] [Related]
17. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
18. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Cui Y; Xu Q; Chow PK; Wang D; Wang CH
Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
[TBL] [Abstract][Full Text] [Related]
19. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.
Melguizo C; Cabeza L; Prados J; Ortiz R; Caba O; Rama AR; Delgado ÁV; Arias JL
Drug Des Devel Ther; 2015; 9():6433-44. PubMed ID: 26715840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]